MediciNova Inc
MNOV
NASDAQ
Biotechnology
$1.31
USD
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $65.46M
Volume 45.1K
Revenue
$596,641
TTM
— YoY
Gross Margin
100%
TTM
— YoY
Net Income
$-11.72M
TTM
-5.0%
YoY
Operating Cash Flow
$-9.50M
TTM
+10.1%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 |
Selling, General & Administrative | 1.4 | 1.6 | 1.9 | 1.7 | 1.8 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 3.2 | 3.7 | 3.5 | 3.2 | 3.0 |
Operating Income | -3.2 | -3.6 | -3.4 | -3.1 | -2.8 |
EBITDA | -3.2 | -3.6 | -3.4 | -3.1 | -2.8 |
Other Income / Expense | 0.0 | 0.0 | -0.0 | -0.0 | -0.0 |
Total Other Income / Expense | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
Income Before Income Taxes | -2.9 | -3.3 | -3.1 | -2.8 | -2.6 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -2.9 | -3.3 | -3.1 | -2.8 | -2.6 |
Consolidated Net Income / Loss | -2.9 | -3.3 | -3.1 | -2.8 | -2.6 |
Net Income Attributable to Common Shareholders | -2.9 | -3.3 | -3.1 | -2.8 | -2.6 |
Basic EPS | -$0.06 | -$0.07 | -$0.06 | -$0.06 | -$0.05 |
Diluted EPS | -$0.06 | -$0.07 | -$0.06 | -$0.06 | -$0.05 |
Basic Shares Outstanding | 49.0M | 49.0M | 49.0M | 49.1M | 49.2M |
Diluted Shares Outstanding | 49.0M | 49.0M | 49.0M | 49.1M | 49.2M |